Watch for Dovato, a New Combo Med for HIV

Dovato (doh-VAH-toh) will be a new two-drug combo for HIV.

It combines 50 mg of dolutegravir (Tivicay) and 300 mg of lamivudine (Epivir) in a once-daily tab...and is a complete HIV regimen.

Dovato joins Juluca (dolutegravir/rilpivirine)...another two-med, one-pill complete regimen. But Juluca is only for certain patients who've taken HIV meds...Dovato is for those new to treatment.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote